Wendy D. Taylor, MS, serves as Chief Operating Officer, Board Member, and Co-Founder of Liferna. She has more than 25 years of operational and strategic leadership experience across the global biopharmaceutical industry, supporting programs in autoimmune disease and RNA therapeutics.
Before co-founding Liferna, Ms. Taylor served as Vice President of Operations and Strategic Portfolio Management at Arcturus Therapeutics, where she helped scale the company from an early-stage biotech into a public clinical-stage company. She has led global collaborations with organizations including CSL, Johnson & Johnson, Takeda, Lilly, and CureVac, and managed large-scale partnership and development initiatives, including a $63 million BARDA-supported vaccine program.